Tengye Ventures
VC Fund
Beijing, China
Tengye Ventures is a professional investment management firm.
- Total investments:
- 40
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Tengye Ventures invests in
Stages Tengye Ventures invests in
Countries Tengye Ventures invests in
Round sizes
Round size
- Seed
- $2.8M–$15M
Investment Focus
Industry
- Manufacturing 10 (25%)
- Health Care 8 (20%)
- Biotechnology 8 (20%)
- Medical 7 (18%)
- Software 4 (10%)
Stage
- Venture - Series Unknown 13 (33%)
- Seed 10 (25%)
- Funding Round 6 (15%)
- Series A 5 (13%)
- Series B 3 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Physcience Golden Silicon New Material Technology is a technology-driven company that develops and manufactures silicon-based anode materials for lithium batteries. | Dec 27, 2024 | ||
| Cellbri is a manufacturing company that produces and sells automated CGT industrial instruments for cell processing programs. | $27.6M / Series B / Jun 14, 2024 | ||
| Qina New Materials is centered on the manufacturing, exploration, and development of premium special metal materials including wire materials, catalysts, high-temperature alloy master alloys, and electrode meshes for hydrogen production. | $27.8M / Series C / Mar 06, 2024 | ||
|
Dream Chasing Sky
|
Dream Chasing Sky specializes on electric vertical take-off and landing aircraft research and development. | Seed / Sep 11, 2023 | |
| Zhitian Xinhang provides shock absorbers, vibration isolators, sealing rings, and other products. | $1.5M / Series A / Feb 17, 2023 | ||
| Zhitian Xinhang is a supplier of high-performance vibration damping and anti-shock solutions. | Series A / Feb 17, 2023 | ||
|
Hengdong Bio
|
Hengdong Bio is dedicated to developing agonist antibody drugs with the potential to become new drugs, utilizing its advanced and unique core technology platform for screening, optimizing, and evaluating agonist antibodies. | Seed / Aug 08, 2022 | |
| I-Join was Established in April 2015, it is located in Shanghai Zhangjiang Medical Device Industry Base, No. 528 Ruiqing Road, Shanghai, and has obtained the "Medical Device Production License". It consists of six departments of R&D, production, quality, finance, marketing, and integration, with about 50 team members. Industrialintegration R&D team. It has built a 10,000-level clean production workshop and laboratory and has the research and development, testing, and production conditions for Class III sterile medical devices. | Venture - Series Unknown / Jan 01, 2021 | ||
Untramine Intelligence
|
Untramine Intelligence is a teaching-free programming intelligent industrial robot system for industrial applications. | Venture - Series Unknown / Jan 01, 2021 | |
Angel Reach
|
Angel Reach is an integrated third-third thoracic aortic stent graft system. | Venture - Series Unknown / Jan 01, 2021 | |
| See all 40 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tengye Ventures invest in?
Tengye Ventures invests primarily in Manufacturing, Health Care and Biotechnology startups, most often at Venture - Series Unknown and Seed stage. Most of the 40 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Tengye Ventures invest in?
Tengye Ventures typically joins rounds of $2.8M–$15M at Seed. These are whole funding-round sizes, not Tengye Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Tengye Ventures took part in.
When did Tengye Ventures last invest?
The most recent investment recorded for Tengye Ventures closed in Dec 2024. Shizune tracks 40 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
